Related Experiment Videos
Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1
Dan A Dixon1, Glen C Balch, Nancy Kedersha
1Surgical Oncology Research Laboratory, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN 37232-2733, USA. dan.dixon@vanderbilt.edu
Abstract:
The cyclooxygenase-2 (COX-2) enzyme catalyzes the rate-limiting step of prostaglandin formation in inflammatory states, and COX-2 overexpression plays a key role in carcinogenesis. To understand the mechanisms regulating COX-2 expression, we examined its posttranscriptional regulation mediated through the AU-rich element (ARE) within the COX-2 mRNA 3'-untranslated region (3'UTR). RNA binding studies, performed to identify ARE-binding regulatory factors, demonstrated binding of the translational repressor protein TIA-1 to COX-2 mRNA. The significance of TIA-1-mediated regulation of COX-2 expression was observed in TIA-1 null fibroblasts that produced significantly more COX-2 protein than wild-type fibroblasts. However, TIA-1 deficiency did not alter COX-2 transcription or mRNA turnover. Colon cancer cells demonstrated to overexpress COX-2 through increased polysome association with COX-2 mRNA also showed defective TIA-1 binding both in vitro and in vivo. These findings implicate that TIA-1 functions as a translational silencer of COX-2 expression and support the hypothesis that dysregulated RNA-binding of TIA-1 promotes COX-2 expression in neoplasia.
Insights
The translational repressor TIA-1 silences cyclooxygenase-2 (COX-2) expression by binding its mRNA. Defective TIA-1 binding promotes COX-2 overexpression in cancer, highlighting its role in neoplasia.
Area of Science:
- Molecular Biology
- Cancer Research
- RNA Biology
Background:
- Cyclooxygenase-2 (COX-2) is crucial in inflammation and carcinogenesis.
- COX-2 overexpression is linked to cancer development.
- Posttranscriptional regulation via AU-rich elements (AREs) affects gene expression.
Purpose of the Study:
- To investigate the role of TIA-1 in regulating COX-2 mRNA.
- To understand how TIA-1 binding to the COX-2 3'-untranslated region (3'UTR) impacts protein expression.
- To explore the implications of TIA-1 dysfunction in cancer.
Main Methods:
- RNA binding assays to identify regulatory factors.
- Analysis of COX-2 protein levels in TIA-1 null and wild-type fibroblasts.
- Assessment of COX-2 mRNA transcription and turnover rates.
- In vitro and in vivo studies of TIA-1 binding in colon cancer cells.
Main Results:
- TIA-1 directly binds to COX-2 mRNA.
- TIA-1 deficiency leads to increased COX-2 protein production without affecting transcription or mRNA stability.
- Colon cancer cells overexpressing COX-2 exhibit impaired TIA-1 binding.
- TIA-1 acts as a translational repressor for COX-2 mRNA.
Conclusions:
- TIA-1 functions as a translational silencer of COX-2.
- Dysregulated TIA-1 RNA binding contributes to COX-2 overexpression in neoplastic conditions.
- Targeting TIA-1 interactions may offer therapeutic strategies for COX-2-driven cancers.